Publication date: Jul 22, 2025
Surveillance after colorectal cancer (CRC) resection is an important aspect of survivorship care. This study aimed to assess whether there were any changes to post-operative surveillance uptake in non-metastatic CRC patients and pre- and post-COVID pandemic in Victoria. All CRC patients (Stages I-III) who underwent curative surgery at Western Health, Victoria, Australia, were included. Surveillance included a three-monthly clinical review and carcinoembryonic antigen (CEA) up to 18 months and CT imaging and colonoscopy at 12 months following surgical resection. Between 2019 and 2022, 380 patients were identified. Stage III patients had the highest uptake with regard to clinical reviews, CEA testing and 12-month CT (83. 3%, 60. 3% and 85. 5%, respectively) while Stage I patients had the lowest (52. 7%, 35. 7% and 75. 5% respectively) (p
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Colorectal cancer |
| pathway | KEGG | Colorectal cancer |
| disease | MESH | COVID-19 |
| disease | MESH | Cancer |